When properly made, both deliver the same 15% to 22% body weight loss over 6 to 12 months
Lung Diseases, Interstitial
Cardiovascular markers Orforglipron demonstrated significant improvements in waist circumference, systolic blood pressure, triglyceride levels, and non-HDL cholesterol in the ATTAIN-1 trial
99.276% purity (HPLC) Third-party tested Freedom Diagnostics Identity confirmed Certificate of Analysis Tested by Freedom Diagnostics 03/23/2026 Tested by Janoshik 11/10/2025 Key Ingredients A stable pentadecapeptide (15 amino acids) studied in relation to cytoprotective mechanisms, nitric oxide system interactions, growth factor expression, and angiogenic pathways
Rated 5 out of 5 Killea Deseve (verified owner) Verified review - view original Worked great for me
The FDA has established an import alert to help block GLP-1 active pharmaceutical ingredients with potential quality concerns from entering the US supply chain, while emphasizing that compounded drugs should only be used when a patients medical needs cannot be met by an FDA-approved alternative
